ArticleThe Journal of experimental medicine1998

gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligand.

W W Overwijk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.